SOURCE-LINKED INTELLIGENCE

Robust Explainable Controllable Standard for drug Screening

CORDIS · observation · Publication date unknown

drugs, 1,599 diseases, 12 feature types). It is primarily supervised by Pr. Olaf Wolkenhauer, at SBI Rostock, whose team has an expertise in drug repurposing, in systems biology and data imbalance in machine learning. This project will help the fellow develop new skills, and enhance her professional maturity in academia. In the short term, this would yield the first method that fully integrates biological interpretation and risk assessment to collaborative filtering-based repurposing. Long-term outcomes might help define sustainable and transparent drug development for rare diseases. drug repurposing collaborative filtering in silico drug screening statistical testing

Read original source ↗ Open in workspace

recordType

award

status

TERMINATED

region

EU

value

189687.36

unit

EUR